Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Axial Spondyloarthritis: Expert Answers to FAQs

Expert answers to common questions on diagnosis and management of axial spondyloarthritis.
Format: Adobe Acrobat (.pdf)
File Size: 102 KB
Released: September 30, 2020


Provided by Purdue University College of Pharmacy
Purdue University Logo

Accreditation: Dawn Sinclair, Purdue University sinclaid@purdue.edu
Certificates/Credits: Heather Holley, Purdue University hholley@purdue.edu

This activity is supported by educational funding provided by
AbbVie Inc.
Novartis Pharmaceuticals Corporation

Related Content

Free editable slides from CCO: best practice for diagnosis and treatment of axial spondyloarthritis. With Drs. Susan Burke, Atul Deodhar, Marina N. Magrey

Atul Deodhar, MD
Program Director
M. Susan Burke, MD, FACP Marina N. Magrey, MD
Released: July 30, 2020

Despite demonstration of comparable efficacy and safety between biosimilars and their originators, some patients avoid this treatment switch. Here’s my take on steps to assuage unfounded patient fears.

Jonathan Kay, MD Released: February 13, 2018

Watch our recent quiz game on biosimilars in rheumatologic conditions.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: November 28, 2017 Expired: No longer available for credit

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.